Clinical Trials Browser

Phase 1/2 × Biliary Tract Carcinoma × donafenib × Clear all

NCT04979663 2021-08-09

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Carcinoma